Development & Filing of Orphan/ Generic Drugs & APIs: Regulative Needs

Development & Filing of Orphan/ Generic Drugs & APIs: Regulative Needs

A Comparative Study on Regulatory Needs for the Development & Filing of Orphan/ Generic Drugs & APIs in Selected Country

Versandkostenfrei!
Versandfertig in 6-10 Tagen
40,99 €
inkl. MwSt.
PAYBACK Punkte
20 °P sammeln!
The medicament allowance in the US, Europe & India are of utmost importance in the world. The goal of the laws governing medicinal articles in US, Europe & India is to protect citizens' fitness and provide with the improvised quality of life.The primary motive of this study wasthe comparative investigation of development and filing process of Orphan Drugs, Generic Drugs and APIsin US, Europe & India.Results of comparative analysis of generic drug filing haveshowed that nine out of the ten jurisdictions had mandated drug approval timelines. A comparative study on the regulatory review process a...